Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in China: A Randomized Clinical Trial.
暂无分享,去创建一个
M. Woodward | E. Peterson | K. Chalkidou | Anushka Patel | Y. Huo | Yangfeng Wu | D. Hu | Xian Li | L. Kong | L. Billot | Xin Du | Shenshen Li | Tao Wu | Yifei Zhao | Lin Feng | R. Gao | Y. Huo
[1] D. Peters,et al. Effectiveness of strategies to improve health-care provider practices in low-income and middle-income countries: a systematic review , 2018, The Lancet. Global health.
[2] Lihui Zhao,et al. Effect of a Quality Improvement Intervention on Clinical Outcomes in Patients in India With Acute Myocardial Infarction: The ACS QUIK Randomized Clinical Trial , 2018, JAMA.
[3] S. Nuti,et al. Fibrinolytic therapy in hospitals without percutaneous coronary intervention capabilities in China from 2001 to 2011: China PEACE-retrospective AMI study , 2017, European heart journal. Acute cardiovascular care.
[4] M. Malik,et al. ACUTE CORONARY SYNDROME AND ITS SUB-TYPES AMONG PATIENTS ADMITTED IN CHEST PAIN UNIT , 2017 .
[5] Ashutosh Kumar Singh,et al. Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990–2015: a systematic analysis for the Global Burden of Disease Study 2015 , 2016, Lancet.
[6] E. Peterson,et al. Rational and design of a stepped-wedge cluster randomized trial evaluating quality improvement initiative for reducing cardiovascular events among patients with acute coronary syndromes in resource-constrained hospitals in China. , 2015, American heart journal.
[7] Harlan M Krumholz,et al. ST-segment elevation myocardial infarction in China from 2001 to 2011 (the China PEACE-Retrospective Acute Myocardial Infarction Study): a retrospective analysis of hospital data , 2015, The Lancet.
[8] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[9] Bernadette A. Thomas,et al. Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.
[10] I. Ranasinghe,et al. Hospital Quality Improvement Initiative for Patients With Acute Coronary Syndromes in China: A Cluster Randomized, Controlled Trial , 2014, Circulation. Cardiovascular quality and outcomes.
[11] Jane A. Linderbaum,et al. 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. , 2013, Journal of the American College of Cardiology.
[12] Therese Hesketh,et al. Violence against doctors in China , 2012, BMJ : British Medical Journal.
[13] E. Peterson,et al. Effect of a multifaceted intervention on use of evidence-based therapies in patients with acute coronary syndromes in Brazil: the BRIDGE-ACS randomized trial. , 2012, JAMA.
[14] M. Flather,et al. Cluster-randomized trial to evaluate the effects of a quality improvement program on management of non-ST-elevation acute coronary syndromes: The European Quality Improvement Programme for Acute Coronary Syndromes (EQUIP-ACS). , 2011, American Heart Journal.
[15] Judith S. Hochman,et al. 2011 ACCF/AHA Focused Update Incorporated Into the ACC/AHA 2007 Guidelines for the Management of Patients With Unstable Angina/Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines , 2011, Circulation.
[16] F. Turnbull,et al. Clinical pathways for acute coronary syndromes in China: protocol for a hospital quality improvement initiative. , 2010, Critical pathways in cardiology.
[17] Thomas Rotter,et al. Clinical pathways: effects on professional practice, patient outcomes, length of stay and hospital costs. , 2010, The Cochrane database of systematic reviews.
[18] Zhu Chen,et al. Launch of the health-care reform plan in China , 2009, The Lancet.
[19] Lingzhi Kong,et al. Evidence-based medication use among Chinese patients with acute coronary syndromes at the time of hospital discharge and 1 year after hospitalization: results from the Clinical Pathways for Acute Coronary Syndromes in China (CPACS) study. , 2009, American heart journal.
[20] L. Goldman,et al. The future impact of population growth and aging on coronary heart disease in China: projections from the Coronary Heart Disease Policy Model-China , 2008, BMC public health.
[21] Shanlian Hu,et al. Reform of how health care is paid for in China: challenges and opportunities , 2008, The Lancet.
[22] F. Turnbull,et al. Prospective observational study of acute coronary syndromes in China: practice patterns and outcomes , 2007, Heart.
[23] J. Hughes,et al. Design and analysis of stepped wedge cluster randomized trials. , 2007, Contemporary clinical trials.
[24] A. Turpie. Burden of disease: medical and economic impact of acute coronary syndromes. , 2006, The American journal of managed care.
[25] Ron Goeree,et al. Effect of a clinical pathway to reduce hospitalizations in nursing home residents with pneumonia: a randomized controlled trial. , 2006, JAMA.
[26] Elizabeth R DeLong,et al. ORIGINAL CONTRIBUTION Association Between Hospital Process Performance and Outcomes Among Patients With Acute Coronary Syndromes , 2022 .
[27] R. Collins,et al. Addition of clopidogrel to aspirin in 45 852 patients with acute myocardial infarction: randomised placebo-controlled trial , 2005, The Lancet.
[28] Anne Mills,et al. The effect of performance-related pay of hospital doctors on hospital behaviour: a case study from Shandong, China , 2005, Human resources for health.
[29] Robert Parrish,et al. Improving quality of care for acute myocardial infarction: The Guidelines Applied in Practice (GAP) Initiative. , 2002, JAMA.
[30] S. Yusuf,et al. Global burden of cardiovascular diseases: Part II: variations in cardiovascular disease by specific ethnic groups and geographic regions and prevention strategies. , 2001, Circulation.
[31] H. White,et al. Thrombin-specific anticoagulation with bivalirudin versus heparin in patients receiving fibrinolytic therapy for acute myocardial infarction: the HERO-2 randomised trial , 2001, The Lancet.
[32] J J Allison,et al. Improving quality improvement using achievable benchmarks for physician feedback: a randomized controlled trial. , 2001, JAMA.